Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$7.45 - $13.84 $197,492 - $366,884
-26,509 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$9.94 - $12.65 $137,191 - $174,595
-13,802 Reduced 34.24%
26,509 $322,000
Q2 2021

Jul 12, 2021

BUY
$12.38 - $29.19 $499,050 - $1.18 Million
40,311 New
40,311 $575,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.